Humalog and Methylcobalamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humalog (insulin lispro recombinant) and Methylcobalamin (vitamin b12). Common drug interactions include rotator cuff syndrome among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Humalog and Methylcobalamin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.

What is Methylcobalamin?

Methylcobalamin has active ingredients of vitamin b12. It is often used in vitamin b12 deficiency. eHealthMe is studying from 3,184 Methylcobalamin users. Check the latest studies of Methylcobalamin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

23 people who take Humalog and Methylcobalamin together, and have interactions are studied.

Humalog and Methylcobalamin drug interactions.

What are the common drug interactions of Humalog and Methylcobalamin, by gender? *:

female:

  1. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  2. Hypertension (high blood pressure)
  3. Eye disorder
  4. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  5. Cardiac failure chronic
  6. Cerebral infarction (less blood supply to brain resulting tissue damage)
  7. Diabetic foot
  8. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  9. Neuropathy peripheral (surface nerve damage)
  10. Pneumonia

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Hypercholesterolaemia (high levels of cholesterol in the blood)
  3. Hypertension (high blood pressure)
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Intestinal perforation (complete penetration of the wall of the intestine)
  6. Malignant anorectal neoplasm (cancerous tumour of anus or rectum)
  7. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
  8. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  9. Pain in extremity
  10. Rash

What are the common drug interactions of Humalog and Methylcobalamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Hypercholesterolaemia (high levels of cholesterol in the blood)
  3. Cardiac failure
  4. Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
  5. Eye disorder

60+:

  1. Hypertension (high blood pressure)
  2. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Intestinal perforation (complete penetration of the wall of the intestine)
  5. Malignant anorectal neoplasm (cancerous tumour of anus or rectum)
  6. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
  7. Pneumonia
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Septic shock (shock due to blood infection)
  10. Urinary tract infection

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 4 people, 17.39%
  2. Constipation: 4 people, 17.39%
  3. Scleritis (inflammation of sclera): 2 people, 8.70%
  4. Pulmonary Artery Thrombosis (blockage of the main artery of the lung): 2 people, 8.70%
  5. Muscle Aches (muscle pain): 2 people, 8.70%
  6. Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 2 people, 8.70%
  7. Lipid Metabolism Disorder (genetic disorders are caused by errors in fatty acid metabolism): 2 people, 8.70%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%
  9. Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 2 people, 8.70%
  10. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog and Methylcobalamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Humalog and Methylcobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methylcobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylcobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin lispro recombinant and vitamin b12 (the active ingredients of Humalog and Methylcobalamin, respectively), and Humalog and Methylcobalamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: